Annual EBITDA
$14.99B$473.00M+3.26%
Summary
- Current Value
- As of today, CVS annual EBITDA is $14.99B, up +3.26% on
- Historical Performance
- CVS annual EBITDA is down -28.05% over the past 3 years, down -18.36% over the past 5 years
- All-Time High Comparison
- CVS annual EBITDA is currently -28.05% below its historical high of $20.83B set on
- 3-Year Low Comparison
- CVS annual EBITDA is +3.26% above its 3-year low of $14.52B reached on
- Sector Comparison
- CVS annual EBITDA is higher than 98.85% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $14.99B | +3.3% | -28.1% | -18.4% | +96.4% | |
| Quarterly EBITDA | $4.71B | +15.0% | -7.0% | +0.9% | +136.5% | |
| TTM EBITDA | $19.85B | +15.6% | -0.5% | +6.3% | +157.7% | |
| Price | $83.85 | +6.6% | +18.0% | -10.6% | +120.5% | |
| PE Ratio | 9.75 | -95.3% | -8.7% | -40.5% | -35.3% | |
| Annual Revenue | $402.11B | +7.9% | +24.6% | +49.7% | +317.1% | |
| Annual EPS | $1.39 | -62.0% | -57.3% | -74.5% | -44.1% | |
| Annual EBIT | $10.39B | +4.7% | -37.5% | -25.4% | +68.5% | |
| Annual Net Income | $1.73B | -62.3% | -60.1% | -76.0% | -49.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $20.83B | N/A | -28.1% |
| 5Y | $20.83B | -28.1% | |
| All | $20.83B | -28.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $14.52B | +3.3% | |
| 5Y | $14.52B | +3.3% | |
| All | $256.32M | +5748.5% |
EBITDA History
FAQ
- What is the current annual EBITDA of CVS?
- As of today, CVS annual EBITDA is $14.99B
- What is 1-year change in CVS annual EBITDA?
- CVS annual EBITDA is up +3.26% year-over-year
- What is 3-year change in CVS annual EBITDA?
- CVS annual EBITDA is down -28.05% over the past 3 years
- How far is CVS annual EBITDA from its all-time high?
- CVS annual EBITDA is currently -28.05% below its historical high of $20.83B set on December 31, 2022
- How does CVS annual EBITDA rank versus sector peers?
- CVS annual EBITDA is higher than 98.85% of companies in Healthcare sector
- When is CVS next annual earnings release?
- The next annual earnings release for CVS is on
EBITDA Formula
Quarterly EBITDA
$4.71B$1.14B-19.55%
Summary
- Current Value
- As of today, CVS quarterly EBITDA is $4.71B, down -19.55% on
- Historical Performance
- CVS quarterly EBITDA is up +15.03% year-over-year, down -7.03% over the past 3 years
- All-Time High Comparison
- CVS quarterly EBITDA is currently -19.55% below its historical high of $5.85B set on
- 3-Year Low Comparison
- CVS quarterly EBITDA is +47.86% above its 3-year low of $3.18B reached on
- Sector Comparison
- CVS quarterly EBITDA is higher than 98.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $4.71B | -19.6% | +15.0% | -7.0% | +0.9% | |
| Annual EBITDA | $14.99B | – | +3.3% | -28.1% | -18.4% | |
| TTM EBITDA | $19.85B | +3.2% | +15.6% | -0.5% | +6.3% | |
| Price | $83.85 | -12.9% | +6.6% | +18.0% | -10.6% | |
| PE Ratio | 9.75 | -61.6% | -95.3% | -8.7% | -40.5% | |
| Quarterly Revenue | $108.40B | +2.2% | +5.4% | +20.6% | +46.9% | |
| Quarterly EPS | $1.68 | -27.3% | +153.7% | -4.0% | +39.9% | |
| Quarterly EBIT | $3.58B | -24.3% | +20.9% | -9.2% | +1.2% | |
| Quarterly Net Income | $2.17B | -27.5% | +154.4% | -4.2% | +36.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.85B | -19.6% | |
| 3Y | $5.85B | -19.6% | |
| 5Y | $5.85B | -19.6% | |
| All | $5.85B | -19.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.46B | +35.9% | |
| 3Y | $3.18B | +47.9% | |
| 5Y | $3.18B | +47.9% | |
| All | -$3.90B | +220.7% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of CVS?
- As of today, CVS quarterly EBITDA is $4.71B
- What is CVS quarterly EBITDA most recent change?
- CVS quarterly EBITDA was down -19.55% on September 30, 2026
- What is 1-year change in CVS quarterly EBITDA?
- CVS quarterly EBITDA is up +15.03% year-over-year
- How far is CVS quarterly EBITDA from its all-time high?
- CVS quarterly EBITDA is currently -19.55% below its historical high of $5.85B set on June 30, 2026
- How does CVS quarterly EBITDA rank versus sector peers?
- CVS quarterly EBITDA is higher than 98.79% of companies in Healthcare sector
- When is CVS next earnings release?
- The next earnings release for CVS is on
EBITDA Formula
TTM EBITDA
$19.85B$615.00M+3.20%
Summary
- Current Value
- As of today, CVS TTM EBITDA is $19.85B, up +3.20% on
- Historical Performance
- CVS TTM EBITDA is up +15.62% year-over-year, down -0.50% over the past 3 years
- All-Time High Comparison
- CVS TTM EBITDA is currently -4.39% below its historical high of $20.76B set on
- 3-Year Low Comparison
- CVS TTM EBITDA is +36.71% above its 3-year low of $14.52B reached on
- Sector Comparison
- CVS TTM EBITDA is higher than 99.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $19.85B | +3.2% | +15.6% | -0.5% | +6.3% | |
| Annual EBITDA | $14.99B | – | +3.3% | -28.1% | -18.4% | |
| Quarterly EBITDA | $4.71B | -19.6% | +15.0% | -7.0% | +0.9% | |
| Price | $83.85 | -12.9% | +6.6% | +18.0% | -10.6% | |
| PE Ratio | 9.75 | -61.6% | -95.3% | -8.7% | -40.5% | |
| TTM Revenue | $420.63B | +1.3% | +6.8% | +20.8% | +47.6% | |
| TTM EPS | $8.60 | +127.1% | +2148.5% | +29.3% | +50.4% | |
| TTM EBIT | $15.33B | +4.2% | +22.0% | -2.2% | +8.4% | |
| TTM Net Income | $11.05B | +126.1% | +2480.8% | +27.7% | +45.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $19.85B | at high | |
| 3Y | $19.95B | -0.5% | |
| 5Y | $20.76B | -4.4% | |
| All | $20.76B | -4.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $17.17B | N/A | +15.6% |
| 3Y | $14.52B | +36.7% | |
| 5Y | $14.52B | +36.7% | |
| All | -$3.55B | +658.6% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of CVS?
- As of today, CVS TTM EBITDA is $19.85B
- What is CVS TTM EBITDA most recent change?
- CVS TTM EBITDA was up +3.20% on September 30, 2026
- What is 1-year change in CVS TTM EBITDA?
- CVS TTM EBITDA is up +15.62% year-over-year
- How far is CVS TTM EBITDA from its all-time high?
- CVS TTM EBITDA is currently -4.39% below its historical high of $20.76B set on December 31, 2022
- How does CVS TTM EBITDA rank versus sector peers?
- CVS TTM EBITDA is higher than 99.20% of companies in Healthcare sector
- When is CVS next earnings release?
- The next earnings release for CVS is on
EBITDA Formula
Data Sources & References
- CVS Official Website www.cvshealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm
- CVS Profile on Yahoo Finance finance.yahoo.com/quote/CVS
- CVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvs
